Identification of Circulating MiRNAs Differentially Regulated by Opioid Treatment

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2017 Sep 21

PMID 28926935

Citations 26

Authors

Kaoru Toyama

Naoki Kiyosawa

Kenji Watanabe

Hitoshi Ishizuka

Affiliations

Soon will be listed here.

Abstract

Emerging evidence demonstrates functional contributions of microRNAs (miRNAs) to μ-opioid receptor (MOR) signaling, but the information so far has been mostly limited to their intracellular regulatory mechanisms. The present study aimed to investigate changes in plasma miRNA profiles elicited by opioid treatment in blood samples collected from clinical studies. Healthy male subjects were orally administered with hydromorphone or oxycodone and blood samples were collected at a specified time after the drug treatment. A total of 179 plasma miRNAs were measured using multiplex qRT-PCR. Nine and seventeen miRNAs were commonly upregulated (let-7a-5p, miR-423-3p, miR-199a-3p, miR-146a-5p, miR-23b-3p, miR-24-3p, miR-221-3p, miR-223-3p, and miR-146b-5p) and downregulated (miR-144-3p, miR-215, miR-363-3p, etc.), respectively, following opioid treatment. The MOR signaling-associated miRNAs, namely let-7 family miRNAs (i.e., let-7d-5p, let-7f-5p, let-7c, let-7e-5p), miR-103a-3p, miR-339-3p, miR-146a-5p, miR-23b-3p, miR-23a-3p, and miR-181a-5p, were differentially expressed following drug treatment. These differentially expressed miRNAs are circulating biomarker candidates that can be used to evaluate MOR stimulation and serve as novel clinical diagnostic tools for improving clinical outcomes.

Citing Articles

Pharmacogenetic landscape of pain management variants among Mediterranean populations.

Jmel H, Boukhalfa W, Gouiza I, Seghaier R, Dallali H, Kefi R Front Pharmacol. 2024; 15:1380613.

PMID: 38813106 PMC: 11134176. DOI: 10.3389/fphar.2024.1380613.

A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy.

Lewandrowski K, Sharafshah A, Elfar J, Schmidt S, Blum K, Wetzel F Cell Mol Neurobiol. 2024; 44(1):47.

PMID: 38801645 PMC: 11129978. DOI: 10.1007/s10571-024-01466-5.

Neuroplasticity-related genes correlate with individual differences in distinct phases of oxycodone self-administration in male rats.

Vassoler F, Budge K, Isgate S, Gildawie K, Byrnes E Neuropharmacology. 2024; 254:109972.

PMID: 38710443 PMC: 11164234. DOI: 10.1016/j.neuropharm.2024.109972.

MicroRNA-mediated translational pathways are regulated in the orbitofrontal cortex and peripheral blood samples during acute abstinence from heroin self-administration.

Zanda M, Saikali L, Morris P, Daws S Adv Drug Alcohol Res. 2024; 3:11668.

PMID: 38389822 PMC: 10880771. DOI: 10.3389/adar.2023.11668.

Emergence of Extracellular Vesicles as "Liquid Biopsy" for Neurological Disorders: Boom or Bust.

Kumar A, Nader M, Deep G Pharmacol Rev. 2024; 76(2):199-227.

PMID: 38351075 PMC: 10877757. DOI: 10.1124/pharmrev.122.000788.

References

Higa G, de Sousa E, Walter L, Kinjo E, Resende R, Kihara A . MicroRNAs in neuronal communication. Mol Neurobiol. 2014; 49(3):1309-26. DOI: 10.1007/s12035-013-8603-7. View

Chandrasekar V, Dreyer J . microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci. 2009; 42(4):350-62. DOI: 10.1016/j.mcn.2009.08.009. View

Upadhyay J, Anderson J, Baumgartner R, Coimbra A, Schwarz A, Pendse G . Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine. Neuroimage. 2011; 59(4):3762-73. DOI: 10.1016/j.neuroimage.2011.11.034. View

Wu Q, Zhang L, Law P, Wei L, Loh H . Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol Pharmacol. 2009; 75(4):744-50. PMC: 2684920. DOI: 10.1124/mol.108.053462. View

Al-Hasani R, Bruchas M . Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011; 115(6):1363-81. PMC: 3698859. DOI: 10.1097/ALN.0b013e318238bba6. View

Zheng H, Zeng Y, Zhang X, Chu J, Loh H, Law P . mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD. Mol Pharmacol. 2009; 77(1):102-9. PMC: 2802427. DOI: 10.1124/mol.109.060848. View

Xu C, Zhang Y, Zheng H, Loh H, Law P . Morphine modulates mouse hippocampal progenitor cell lineages by upregulating miR-181a level. Stem Cells. 2014; 32(11):2961-72. PMC: 4198488. DOI: 10.1002/stem.1774. View

Arroyo J, Chevillet J, Kroh E, Ruf I, Pritchard C, Gibson D . Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011; 108(12):5003-8. PMC: 3064324. DOI: 10.1073/pnas.1019055108. View

Srivastava A, Filant J, Moxley K, Sood A, McMeekin S, Ramesh R . Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment. Curr Gene Ther. 2014; 15(2):182-92. DOI: 10.2174/1566523214666141224100612. View

10.

Kozomara A, Griffiths-Jones S . miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2013; 42(Database issue):D68-73. PMC: 3965103. DOI: 10.1093/nar/gkt1181. View

11.

Dave R, Khalili K . Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system. J Cell Biochem. 2010; 110(4):834-45. PMC: 2923828. DOI: 10.1002/jcb.22592. View

12.

Lu Y, Cao D, Jiang B, Yang T, Gao Y . MicroRNA-146a-5p attenuates neuropathic pain via suppressing TRAF6 signaling in the spinal cord. Brain Behav Immun. 2015; 49:119-29. DOI: 10.1016/j.bbi.2015.04.018. View

13.

Lu Z, Xu J, Xu M, Pasternak G, Pan Y . Morphine regulates expression of μ-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the μ-opioid receptor (OPRM1) gene via miR-103/miR-107. Mol Pharmacol. 2013; 85(2):368-80. PMC: 3913361. DOI: 10.1124/mol.113.089292. View

14.

Toyama K, Uchida N, Ishizuka H, Sambe T, Kobayashi S . Single-dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate-release and hydrophilic matrix extended-release tablets in healthy Japanese subjects without co-administration of an opioid antagonist. J Clin Pharmacol. 2015; 55(9):975-84. DOI: 10.1002/jcph.501. View

15.

Boyerinas B, Park S, Hau A, Murmann A, Peter M . The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer. 2009; 17(1):F19-36. DOI: 10.1677/ERC-09-0184. View

16.

Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, Watanabe Y . Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010; 5(10):e13247. PMC: 2951912. DOI: 10.1371/journal.pone.0013247. View

17.

Toyama K, Furuie H, Kuroda K, Ishizuka H . Pharmacokinetic Bioequivalence Studies of an Extended-Release Oxycodone Hydrochloride Tablet in Healthy Japanese Subjects Under Fasting and Fed Conditions Without an Opioid Antagonist. Drugs R D. 2017; 17(3):363-370. PMC: 5629125. DOI: 10.1007/s40268-017-0184-x. View

18.

Ha M, Kim V . Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014; 15(8):509-24. DOI: 10.1038/nrm3838. View

19.

Cortez M, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood A, Calin G . MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011; 8(8):467-77. PMC: 3423224. DOI: 10.1038/nrclinonc.2011.76. View

20.

Im H, Kenny P . MicroRNAs in neuronal function and dysfunction. Trends Neurosci. 2012; 35(5):325-34. PMC: 3565236. DOI: 10.1016/j.tins.2012.01.004. View